APIS · Particle Therapy

Proton vs Carbon-Ion Therapy

Proton and carbon-ion therapy can concentrate radiation dose at a planned depth, reducing exposure beyond the tumor compared with an X-ray beam. Carbon ions also have a stronger biological effect, which can matter for some relatively radioresistant tumors. The useful choice depends on the cancer, its location, previous treatment and the actual radiation plan. You can request a review without choosing a beam type first.

How Radiation Delivers Dose Inside the Body

Radiation dose is energy absorbed by tissue. Dose deposition describes how that energy is delivered along the beam path. External-beam treatment directs radiation into the body from a machine; it does not require an incision to deliver the beam. Normal tissue on the way to a tumor receives some dose too.

X-ray Photon Radiation

An X-ray beam deposits energy along its path and continues beyond a deep tumor. Modern photon techniques, including IMRT and stereotactic radiation, shape beams from several directions to concentrate dose in the target while protecting surrounding tissue.

Protons and the Bragg Peak

A proton beam has an entrance dose, then deposits more energy as it slows near the end of its range. This peak is the Bragg Peak. Beam energy sets the depth; combining energies spreads the high-dose region across the tumor rather than treating it with one narrow peak.

The dose then drops steeply beyond the planned range, called the distal fall-off. This can reduce dose to tissue beyond the target. It does not eliminate entrance dose or exposure to all nearby normal tissue.

Carbon Ions: Similar Range Control, Different Biology

Carbon ions also have a Bragg Peak and a sharp dose fall-off. Interactions with tissue produce lighter fragments, leaving a small dose tail beyond the main carbon-ion range. That tail is included in treatment planning.

The useful comparison is how these beams deposit dose in tissue and how the tumor and nearby organs respond.

The comparison below describes general beam behavior. Your hospital plan shows how the dose would reach the tumor and nearby tissues.

X-rays, Protons and Carbon Ions

General beam properties; actual dose distributions depend on the plan.
Feature X-ray photons Protons Carbon ions
Along the beam path Dose is delivered before, within and beyond a deep target. Entrance dose followed by a high-dose region near the end of the range. Entrance dose followed by a high-dose region near the end of the range.
Beyond the target depth The beam continues; several shaped beams help distribute normal-tissue dose. Steep distal fall-off with little dose beyond the planned range. Steep fall-off with a remaining fragmentation tail.
Biological effect The reference for standard radiation-dose comparisons. Clinical planning includes the proton biological effect. Higher and varying biological effect; explicitly modeled in carbon-ion planning.
Possible reason to use it Can provide an effective, well-shaped plan for many cancers; widely available. Reduce unnecessary dose where the tumor can still receive the prescribed treatment. Combine dose concentration with biological effects useful for some resistant tumors.
What still matters Tumor control, nearby organs, motion, previous radiation, side effects and the patient’s overall treatment needs.

Carbon-Ion Biology Is Separate From the Bragg Peak

The Bragg Peak describes where energy is deposited. Biological effect describes the damage that energy causes in cells. Carbon ions deposit energy more densely along their tracks in the treatment region and can cause damage that tumor cells find harder to repair.

Relative biological effectiveness (RBE) describes this difference for a specified biological effect. It is not one fixed multiplier for every tumor, tissue or point in a carbon-ion beam. The hospital’s planning system accounts for the expected biological dose.

This is one reason carbon ions are used for some relatively radioresistant tumors, including ACC and certain sarcomas. A higher biological effect also requires attention to normal-tissue safety.

Protecting Normal Tissue Near the Tumor

The question is whether the tumor can receive enough radiation without giving too much dose to nearby nerves or organs. These normal structures are called organs at risk.

For example, a skull-base tumor may lie beside the optic nerves and brainstem, while a pelvic recurrence may sit close to bowel, bladder or nerves. Reducing unnecessary dose can matter, particularly after earlier radiation or in children who have many years of life ahead.

The team still needs to account for movement, changes in anatomy and uncertainty in where a particle beam stops. Several beam directions, dose calculations and quality checks help manage those issues. Side effects remain possible, even when a particle plan reduces exposure.

Choosing Treatment for the Cancer and Previous Therapy

Proton therapy has roles in pediatric and adult cancers where reducing normal-tissue dose is important. Carbon-ion programs include some difficult-to-operate ACCs, sarcomas and recurrent rectal tumors. These programs overlap for some diagnoses; the hospital’s published indications are a starting point for review.

Radiation is a local treatment. Widespread disease may need systemic therapy, and a tumor cannot be treated safely simply because it is solid. Surgery, modern photon radiation or another treatment may fit the case better.

Korean Centers and Cancer Types lists the current hospital programs. Previous radiation and another treatment course explains why the earlier dose matters.

Preparation and Treatment Visits

Particle therapy requires positioning, imaging and a checked radiation plan before treatment. The number of sessions depends on the diagnosis and protocol. See separate carbon-ion and proton schedules for dated hospital examples.

Explore the Options for Your Cancer

You can begin before choosing between proton and carbon-ion therapy.

Sources and dates
  1. National Cancer Institute. External Beam Radiation Therapy. Beam types, simulation and delivery; updated page checked October 19, 2026.
  2. QST Hospital. What Is Carbon Ion Radiotherapy? Updated April 1, 2026. Physical and biological effects.
  3. Microdosimetric Approach to NIRS-defined Biological Dose Measurement for Carbon-ion Treatment Beam. Journal of Radiation Research, 2011;52:59–65. Biological dose across the treatment region.
  4. Experimental study of nuclear fragmentation of 200 and 400 MeV/u carbon ions in water for applications in particle therapy. Physics in Medicine & Biology, 2013. Fragment dose beyond the main beam range.
  5. Yonsei Cancer Center program update, August 19, 2026. Korean carbon-ion programs and head-and-neck schedule.
  6. Samsung Medical Center. Proton Therapy, patient information, undated. Proton course and session information; checked October 19, 2026.

Content reviewed October 23, 2026.

Your request has been received.
We will review the submitted information and contact you by email if additional details are required.​